Bristol-Myers Squibb Co (STU:BRM) Current Accrued Expense : €502 Mil (As of Mar. 2024)

View and export this data going back to 1952. Start your Free Trial

What is Bristol-Myers Squibb Co Current Accrued Expense?

Bristol-Myers Squibb Co's Current Accrued Expense for the quarter that ended in Mar. 2024 was €502 Mil.

Bristol-Myers Squibb Co's quarterly Current Accrued Expense declined from Sep. 2023 (€348 Mil) to Dec. 2023 (€320 Mil) but then increased from Dec. 2023 (€320 Mil) to Mar. 2024 (€502 Mil).

Bristol-Myers Squibb Co's annual Current Accrued Expense declined from Dec. 2021 (€335 Mil) to Dec. 2022 (€303 Mil) but then increased from Dec. 2022 (€303 Mil) to Dec. 2023 (€320 Mil).

Bristol-Myers Squibb Co Current Accrued Expense Historical Data

The historical data trend for Bristol-Myers Squibb Co's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Current Accrued Expense Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

443.70

356.75

334.53

303.02

320.03

Bristol-Myers Squibb Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															297.95	280.59	347.63	320.03	502.32

Bristol-Myers Squibb Co Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Bristol-Myers Squibb Co Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co (STU:BRM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (STU:BRM) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (STU:BRM) Headlines

No Headlines